HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Angiogenesis Inducing Agents (Angiogenesis Factor)

Subscribe to New Research on Angiogenesis Inducing Agents

Agents that induce or stimulate the PHYSIOLOGIC ANGIOGENESIS process. This is caused by a number of ANGIOGENIC PROTEINS.

Also Known As:

Angiogenesis Factor; Angiogenesis Stimulating Agents; Angiogenesis Stimulators; Angiogenic Factor; Tumor Angiogenic Factor; Agents, Angiogenesis Inducing; Agents, Angiogenesis Stimulating; Angiogenic Factor, Tumor; Factor, Angiogenesis; Factor, Angiogenic; Factor, Tumor Angiogenic; Inducers, Angiogenesis; Inducing Agents, Angiogenesis; Stimulating Agents, Angiogenesis; Stimulators, Angiogenesis; Angiogenesis Inducers

Networked: 1270 relevant articles (9 outcomes, 110 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Chemical Actions and Uses
- Pharmacologic Actions: 56
  - Physiological Effects of Drugs: 1
    - Growth Substances: 12
      - Angiogenesis Modulating Agents: 11
        Angiogenesis Inducing Agents: 1270

Experts

1.	Ikeda, Ryuji: 10 articles (09/2013 - 03/2002)
2.	Furukawa, Tatsuhiko: 9 articles (09/2013 - 03/2002)
3.	Sivridis, E: 9 articles (04/2010 - 01/2000)
4.	Karumanchi, S Ananth: 8 articles (04/2015 - 02/2004)
5.	Yamada, Katsushi: 8 articles (09/2013 - 03/2002)
6.	Koukourakis, M I: 8 articles (04/2010 - 01/2000)
7.	Giatromanolaki, A: 8 articles (04/2010 - 01/2000)
8.	Yoshiji, Hitoshi: 8 articles (01/2010 - 03/2002)
9.	Harris, A L: 8 articles (09/2006 - 01/2000)
10.	Ikenaka, Yasuhide: 7 articles (01/2010 - 12/2003)

Related Diseases

1.	Neoplasms (Cancer) 04/30/2009 - "We conclude that in mice hVEGF-D is an angiogenic factor associated with improved muscle regeneration after ischemic injury but also with increased incidence of tumor formation with a preference for mammary gland tumors." 01/01/2014 - "Study outcomes included cancer cell proliferation rates and angiogenic factor secretion from cancer cells. " 10/01/2007 - "In this study, we further investigated the role of MEKK3 in embryonic angiogenesis, tumor angiogenesis, and angiogenic factor production. " 01/15/2004 - "The purpose of this study is to develop a high-throughput approach to detect protein expression from hundreds and thousands of samples and to apply this technology to profile circulating angiogenic factor protein levels in patients with gynecological tumors. " 02/01/2003 - "The potential role of angiogenesis stimulators in the pathogenesis of different tumor entities has been confirmed in several studies. "
2.	Ischemia 01/01/2012 - "In this study, we assessed the potential of a new angiogenic factor AGGF1 for therapeutic angiogenesis in a critical limb ischemia model in mice for PAD. " 01/01/2012 - "Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model." 06/01/2010 - "Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia." 09/01/2007 - "It has feasibility for using the HIF-1-HRE system for regulation of angiogenic factor expression in ischemia heart." 07/01/2007 - "The use angiogenesis stimulators for the treatment of chronic ischemia of lower extremities."
3.	Breast Neoplasms (Breast Cancer) 07/01/2009 - "During pregnancy, there was a general increase in each angiogenic factor, but degree of increase from one sampling period to the next was not associated with later breast cancer risk. " 02/01/2007 - "Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer." 03/01/2006 - "Here, we show that ectopic PAR1 expression induces expression of the angiogenic factor Cyr61(CCN1) in breast cancer cells. " 06/01/2003 - "The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives." 01/10/1998 - "It acts as an angiogenesis factor in breast cancer, but paradoxically inhibits proliferation in several breast cancer cell lines. "
4.	Urinary Bladder Neoplasms (Bladder Cancer) 11/01/2001 - "Angiogenesis, angiogenic factor expression and prognosis of bladder cancer." 07/01/1993 - "The purified substance was named bladder cancer angiogenic factor (BCAF). " 07/01/1993 - "An angiogenic factor from human transitional cell cancer of bladder has been purified by protein extraction, cation exchange chromatography, gel filtration high-performance liquid chromatography (GE-HPLC) and reversed-phase high-performance liquid chromatography (RP-HPLC). " 07/01/1993 - "An angiogenic factor from human bladder cancer: the investigation of purification and biological activities." 06/01/1993 - "The purified substance was named as bladder cancer angiogenic factor (BCAF). "
5.	Shock 03/01/2011 - "Extracorporeal cardiac shock wave therapy could effectively induce angiogenesis, up-regulate the expression of angiogenic factor, resulting in an improvement in micro-vascular circulation reconstruction of ischemic myocardial region."

Related Drugs and Biologics

1.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2.	Intercellular Signaling Peptides and Proteins (Growth Factors)
3.	Interleukin-2 (IL2)
4.	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
5.	bevacizumab
6.	Angiostatins
7.	Antibodies
8.	O-(chloroacetylcarbamoyl)fumagillol (TNP 470)
9.	fumagillin
10.	Thymidine Phosphorylase

Related Therapies and Procedures

1.	Immunotherapy
2.	Heterologous Transplantation (Xenotransplantation)
3.	Microbubbles
4.	Drug Therapy (Chemotherapy)
5.	Transplantation (Transplant Recipients)